- Previous Close
18,580.00 - Open
18,600.00 - Bid 18,830.00 x --
- Ask 18,890.00 x --
- Day's Range
18,570.00 - 19,050.00 - 52 Week Range
17,250.00 - 27,200.00 - Volume
21,502 - Avg. Volume
27,217 - Market Cap (intraday)
277.014B - Beta (5Y Monthly) 0.33
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Mar 17, 2025 - Mar 21, 2025
- Forward Dividend & Yield 420.00 (2.27%)
- Ex-Dividend Date Dec 27, 2023
- 1y Target Est
--
Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries. Korea United Pharm Inc. was founded in 1987 and is headquartered in Seoul, South Korea.
www.kup.co.kr--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 033270.KS
View MorePerformance Overview: 033270.KS
Trailing total returns as of 1/6/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 033270.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 033270.KS
View MoreValuation Measures
Market Cap
273.34B
Enterprise Value
182.35B
Trailing P/E
13.25
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.95
Price/Book (mrq)
0.70
Enterprise Value/Revenue
0.64
Enterprise Value/EBITDA
4.20
Financial Highlights
Profitability and Income Statement
Profit Margin
12.40%
Return on Assets (ttm)
6.78%
Return on Equity (ttm)
12.21%
Revenue (ttm)
161.44B
Net Income Avi to Common (ttm)
20.02B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
38.2B
Total Debt/Equity (mrq)
13.85%
Levered Free Cash Flow (ttm)
11.34B